Skip to content

TMO

Thermo Fisher Scientific Inc.

Capital expenditures, 2025
$1.5B
YoY, 2025
+8.9%
5-year CAGR
+0.7%
10-year CAGR
+13.7%

Capital expenditures

Capital expenditures by fiscal year

PeriodCapexYoY
2025$1.5B+8.9%
2024$1.4B−5.3%
2023$1.5B−34.1%
2022$2.2B−11.1%
2021$2.5B+71.2%
2020$1.5B+59.2%
2019$926M+22.2%
2018$758M+49.2%
2017$508M+14.4%
2016$444M+5.0%
2015$423M−1.1%
2014$428M+51.4%
2013$282M−10.4%
2012$315M+20.8%
2011$261M+6.3%
2010$245M+22.7%
2009$200M−24.4%
2008$264M+50.7%
2007$176M—